Mode
Text Size
Log in / Sign up

Cloud-based intelligent management system improves medication adherence 89.2% vs 58.0% in pediatric asthmaSmart monitoring helps children with asthma manage their symptoms better

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider cloud-based management systems to improve medication adherence and lung function in pediatric asthma patients.

This randomized controlled trial enrolled 208 children aged 6 to 12 years with diagnosed asthma to evaluate a cloud-based integrated intelligent management system featuring real-time monitoring and reminders compared to traditional outpatient follow-up methods over a 12.0 month period.

Patients using the intelligent management system showed significantly higher medication adherence (89.2% vs 58.0%, p < 0.001) and improved lung function, with FEV1% predicted change of +12.3% vs +4.2% (p < 0.001). Asthma control scores (C-ACT) were higher in the intervention group (22.5 ± 2.8 vs 18.1 ± 3.2, p < 0.001). Additionally, airway inflammation (FeNO levels) decreased by 42.9% compared to 17.1% in the control group (p < 0.001), and quality of life scores were higher (6.8 ± 0.9 vs 5.1 ± 1.3, p < 0.001).

Safety data regarding adverse events or discontinuations were not reported. Limitations include the need to identify which specific components of the system drove these outcomes and a lack of data on long-term impacts beyond 12 months. The study also noted a need for integrated psychological support. These findings suggest that digital management systems may offer a more effective approach for pediatric asthma management than traditional methods.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in managing pediatric asthma by introducing a technological intervention to improve adherence and outcomes. While previous coverage noted that adding montelukast or tiotropium to ICS showed no significant difference in control at 3 months, this study suggests that digital management systems may provide superior improvements in medication adherence (89.2% vs 58.0%) and lung function over a longer 12.0 month period. It also provides data on FeNO levels, which were previously noted to have limited diagnostic performance for asthma in school-age children.

Managing childhood asthma can be a constant challenge for families. It requires consistent daily effort to keep symptoms under control and ensure the lungs stay healthy. A new study looked at how a smart, cloud-based management system could help kids aged 6 to 12 manage their condition more effectively than traditional outpatient follow-ups.

Researchers followed 208 children over 12 months. Those using the intelligent system, which provided real-time monitoring and reminders, showed much better results across the board. These children were significantly more likely to stick to their medication schedules, with an 89.2% adherence rate compared to 58.0% for those using traditional methods. This consistent care led to better lung function scores and lower levels of airway inflammation.

While the study shows great promise for improving quality of life and asthma control, there are still pieces of the puzzle left to solve. Researchers noted they need more information on which specific parts of the digital system were most helpful and how these results hold up over many years. For now, it offers a promising way to use technology to support children with bronchial asthma.

What this means for you:
A smart monitoring system significantly improved medication habits and lung function in children with asthma.

Common questions

How does this system help children with asthma?

The system uses real-time monitoring and reminders to help kids stay on track. In a study of 208 children, those using the smart system had an 89.2% medication adherence rate compared to 58.0% for those using traditional methods.

Does this technology improve lung health?

Yes, the study showed that kids using the intelligent management system saw a 12.3% improvement in lung function, while those on traditional plans only saw a 4.2% increase over 12 months.

Are there any known risks or side effects?

The study did not report any specific adverse events or safety concerns regarding the use of the cloud-based management system for children with bronchial asthma.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up12.0 mo
PublishedAug 2026
View Original Abstract ↓
OBJECTIVE: Bronchial asthma in children is a prevalent chronic condition that adversely affects respiratory health, leading to significant healthcare costs and diminished quality of life. Current management strategies, primarily involving inhaled corticosteroids and bronchodilators, are often hindered by poor adherence and inadequate monitoring. This study aimed to evaluate the effectiveness of an intelligent management system compared to traditional methods in enhancing asthma management in pediatric patients. METHODS: Utilizing a randomized controlled trial design with a 12-month follow-up, 208 children aged 6-12 years with diagnosed asthma were enrolled, with the experimental group (120 cases) receiving real-time monitoring and reminders through the intelligent system as an addition to traditional follow-ups, while the control group (88 cases) underwent conventional outpatient follow-ups. RESULTS: Key findings indicated that the experimental group exhibited significant improvements in medication adherence (89.2% vs 58.0%,  < 0.001), lung function (FEV1% predicted change +12.3% vs +4.2%,  < 0.001), asthma control levels (C-ACT score 22.5 ± 2.8 vs 18.1 ± 3.2,  < 0.001), and a marked reduction in airway inflammation (FeNO levels decreased by 42.9% vs 17.1%,  < 0.001). Additionally, quality of life scores improved significantly (PAQLQ total score 6.8 ± 0.9 vs 5.1 ± 1.3,  < 0.001). CONCLUSION: This multifaceted intelligent management system, incorporating real-time monitoring, reminders, and remote clinical support, markedly enhances lung function, reduces airway inflammation, and improves quality of life in children with asthma, highlighting its potential as a transformative approach in asthma management. While the comprehensive approach proved effective, further research is needed to identify the most impactful components to facilitate broader implementation. Future research should explore long-term impacts and the integration of psychological support within these management strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.